(Q34080488)

30 July 2017

Have racial disparities in ovarian cancer increased over time? An analysis of SEER data (English)

1 reference

30 July 2017

1 reference

1

Mishka Terplan

1 reference

30 July 2017

Nicholas Schluterman

2

1 reference

30 July 2017

Erica J McNamara

series ordinal

3

1 reference

30 July 2017

J Kathleen Tracy

series ordinal

4

1 reference

30 July 2017

Sarah M Temkin

series ordinal

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

21 November 2011

1 reference

30 July 2017

1 reference

30 July 2017

125

1 reference

30 July 2017

19-24

1 reference

30 July 2017

1

1 reference

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Ethnic differences in survival among women with ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Racial disparities affecting the reproductive health of African-American women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Racial disparities in ovarian cancer surgical care: a population-based analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Race in ovarian cancer treatment and survival: a systematic review with meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.11.025

10.1016/J.YGYNO.2011.11.025

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference